Original Research Article
Year: 2019 | Month: October | Volume: 9 | Issue: 10 | Pages: 152-156
Haematuria in Benign, Prostatic Hyperplasia and Prostatic Carcinoma
Mr. Bernard N. Kafor1, Dr. Godfrey I. Nnadi2, Prof. Wilson I. Onuigbo3
1Medical Laboratory Scientist, Department of Pathology, Federal Medical Centre,Owerri.
2Consultant Pathologist, Department of Pathology Federal Medical centre, Owerri.
3Director, Medical Foundation and Clinic, Enugu.
Corresponding Author: Mr. Bernard N. Kafor
ABSTRACT
Introduction: Haematuria is a common clinical feature in prostatic diseases. Elucidation on its pattern and significance in benign prostatic hyperplasia (BPH) and prostatic cancer (Pca) is important in the search for better diagnosis and treatment/management decision.
Objective: To evaluate the pattern and significance of haematuria in benign prostatic hyperplasia and prostatic carcinoma.
Methodology: Retrospective study of 2,372 prostatic diseases, of which their samples were received in 10% formalin solution, from deferent parts of South Eastern Nigeria. The samples were processed using basic histological techniques and stained with haematoxylin and eosin. Relevant data such as age, diagnosis and haematuria status, were extracted from the request form and subjected to statistical analysis using Statistical Package for Social Science versin16.
Result: A total of 2,317 cases of prostatic diseases were analyzed: 70.60% showed benign prostatic hyperplasia; 29.00% for prostatic carcinoma and 0.4% for others. The mean age for benign prostatic hyperplasia and prostatic carcinoma patients were respectively 62.03 and 66.93 years. The incidence rate of haematuria in prostatic diseases was 12.04%:11.00% in prostatic hyperplasia and 14.75% in carcinoma, with respective age of occurrence of 65.04 and 65.68 years. Statistical test shows, significant difference between the incidence of BPH and that of Pca in prostatic diseases (P value <0.05). Difference in haematuria between the two conditions is not significant; as regards incidence; age of occurrence; peak age of occurrence and rates (Value >0.05).
Conclusion: This study demonstrated that haematuria in both Pca and BPH were the same with respect to age and rate. Furthermore, it confirms the predominance of prostatic hyperplasia in prostatic diseases.
Key words: Haematuria, Benign Prostatic Hyperplasia, Prostatic Carcinoma, Exocrine.